GoonsTrading

RKT Correction Almost Complete

Long
NYSE:RKT   Rocket Companies, Inc.
Inverse Head and Shoulders

RKT is still below the neckline of a 3 month inverse head and shoulders. Both variations of the head and shoulders are two of the most popular formations in trading. It attempted a breakout during the week of December 18th, crossing the $22.50 neckline, but rejected & stayed in a downtrend since. The measured move on this pattern gives RKT a target of between $24.60 and $27.36.

Bullish Pennant

The pennant remains in play as long as RKT can hold at the current price level. Assuming it does, our next significant resistance for this pattern is around $22.40. Price has failed that level multiple times already, and unless we have a large catalyst, it could easily fail again. The next strong resistance after that is $24, where price may reject, and come back to retest the pennant breakout.

Elliott Wave

It seems like RKT is about to finish the final corrective wave down. Price has already bounced off the .382 level (meaning a .618 correction from the recent high in November). I believe the best buy zones to scale into a long position start here, from the .382 retracement to .146. Considering the history of being such a slow mover, I would be looking for June expiration, if not longer. The overall wave 3 target would be the 1.618, at $26.22.

As a potential catalyst, nearly 40% of the RKT float is short sellers. While the amount of time it would take them to cover their positions is not long (about 3 days), this is a high short percentage. If RKT begins moving up quickly, shorts may be subject to a squeeze.

Overall, look to accumulate a long position between $20 and $18. RKT has proven demand in that area (that I left off the chart to keep it a little cleaner), and should show some opportunities for profit taking even if the full move does not play out. Short interest is so high that shorts could quickly get burned, and small caps are clearly coming into favor as we start the new year.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.